Table 3.

Baseline patient complications by geographical region

	All	China	South Asia	East Asia	North Africa	Middle East	Latin America	Russia
Patients with macrovascular complications, n (%)	17,806 (27.2)	2,342 (21.3)	4,946 (23.3)	2,685 (26.8)	979 (24.2)	4,293 (28.7)	335 (29.4)	2,226 (72.4)
Patients with microvascular complications, n (%)	35,078 (53.5)	5,467 (49.6)	8,293 (39.0)	5,615 (56.0)	2,397 (59.4)	9,847 (65.8)	715 (62.8)	2,744 (89.3)
Renal disease, n (%)	18,271 (27.9)	2,455 (22.3)	4,321 (20.3)	2,845 (28.4)	1,077 (26.7)	6,108 (40.8)	376 (33.0)	1,089 (35.4)
Eye problems, n (%)	17,198 (26.3)	2,430 (22.1)	3,464 (16.3)	2,380 (23.7)	1,354 (33.5)	5,081 (33.9)	368 (32.3)	2,121 (69.0)
Foot ulcer, n (%)	3,538 (5.4)	274 (2.5)	1,046 (4.9)	536 (5.3)	147 (3.6)	1,289 (8.6)	85 (7.5)	161 (5.2)
Neuropathy, n (%)	25,179 (38.4)	3,671 (33.3)	5,234 (24.6)	3,706 (36.9)	1,530 (37.9)	7,995 (53.4)	491 (43.1)	2,552 (83.0)

Note: due to the observational nature of this study, not all baseline data were recorded.